CClinicalTrials.gg
CompletedNCT03539107Updated Jan 13, 2020

Voiding Assessment Based on Minimum Spontaneous Void of 150 mL Compared to Retrograde Fill Method After Female Pelvic Floor Reconstructive Surgery

An interventional study of Retrograde bladder fill and spontaneous void in Urinary Incontinence and Pelvic Organ Prolapse, sponsored by Yale University. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-01-13.

Sponsored by Yale University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
110
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

This study will compare voiding assessment based on a minimum spontaneous voided volume of 150 cc with the standard retrograde fill approach in women after pelvic floor procedures.

02

Conditions studied

  • Urinary Incontinence
  • Pelvic Organ Prolapse
03

In context

Urinary Incontinence

1,363 studies on the registry are indexed under Urinary Incontinence; 228 are open to participants now.

This study's enrollment of 110 is above the median of 66 across 1,011 interventional studies indexed under Urinary Incontinence.

Browse Urinary Incontinence studies →

Lead sponsor

Yale University is the lead sponsor of 1,724 studies on the registry; 298 are open to participants now.

Of its 210 completed or terminated interventional studies of FDA-regulated products, 126 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • All 18-year-old or older women who undergo surgery for urinary incontinence and/or pelvic organ prolapse (POP)

Exclusion criteria

Exclusion Criteria:

  • Patients who require prolonged Foley catheter or suprapubic catheter
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
110 participants (actual)

Study arms

  • Experimental
    Spontaneous void

    Subjects will not have retrograde fill of bladder, rather will be required to void 150 mL spontaneously prior to discharge.

    Other: spontaneous void

  • Active comparator
    Retrograde bladder fill

    Subjects will have their bladder retrograde filled with 300mL of fluid prior to a voiding trial.

    Procedure: Retrograde bladder fill

Interventions

  • ProcedureRetrograde bladder fill

    Subjects will have their bladder retrograde filled with 300mL of fluid prior to a voiding trial.

  • Otherspontaneous void

    Subjects will not have retrograde fill of bladder, rather will be required to void 150 mL spontaneously prior to discharge.

06

What researchers measure

Primary outcomes

  1. Failure rate

    The percentage of subjects who did not meet the required voiding assessment criteria and needed catheterization .

    Time frame: Up to 2 days post op

Secondary outcomes

  1. False pass rate

    The percentage of women who initially met the voiding assessment but returned for re-catheterization due to voiding difficulty .

    Time frame: up to 30 days after discharge.

  2. Force of stream (FOS)

    Patient reported force of stream (FOS) during voiding; (0 being no urination, 10 being normal strong flow).

    Time frame: Up to 2 days post op.

  3. Force of stream (FOS)

    Patient reported force of stream (FOS) during voiding; (0 being no urination, 10 being normal strong flow).

    Time frame: Up to 2 days post-surgery.

  4. Patient Satisfaction Questionnaire for Voiding Assessment-method used

    This question asks "How satisfied were you with the method we used to evaluate how well you could urinate after our surgery?" It is measured on a continuum from 0 (very dissatisfied) to 100 (very satisfied).

    Time frame: Up to 2 days post-surgery.

  5. Patient Satisfaction Questionnaire for Voiding Assessment-negative emotions

    This question asks "Did you experience any negative emotions such as fear or anxiety when we were evaluating urination after our surgery?" It is measured on a continuum from 0 (many negative emotions) to 100 (no negative emotions).

    Time frame: Up to 2 days post-surgery.

  6. Patient Satisfaction Questionnaire for Voiding Assessment-recommend method

    This question asks "How likely would you be to recommend to a friend or family member, the method we used to evaluate your urination after our surgery, if they were in the same situation?" It is measured on a continuum from 0 (very unlikely) to 100 (very likely).

    Time frame: Up to 2 days post-surgery.

  7. Patient Satisfaction Questionnaire for Voiding Assessment-convenience of method

    This question asks "How convenient was the method we used to evaluate your urination after our surgery (e.g. time, ease etc.)? It is measured on a continuum from 0 (very inconvenient) to 100 (very convenient).

    Time frame: Up to 2 days post-surgery.

  8. Patient Satisfaction Questionnaire for Voiding Assessment-preferred method

    This question asks the patient: "If it was all up to you, which It is measured on a continuum from 0 (strongly prefer backfill before catheter) to 100 (strongly prefer no backfill before catheter removal).

    Time frame: Up to 2 days post-surgery.

  9. Postoperative pain score

    This outcome is measured by a 10-point visual analog scale where 0= no pain, 10=worst pain you have ever experienced.

    Time frame: One day post-surgery.

  10. Urinary tract infection (UTI)

    UTI is defined as culture-proven bladder infection or, in the absence of a culture, clinical suspicion of a bladder infection that resulted in treatment.

    Time frame: Up to 30 days post surgery.

  11. Post-operative complications

    Post-operative complications assessed by medical record review.

    Time frame: Up to 30 days post-surgery.

  12. Length of hospital stay

    Length of hospital stay assessed by medical record review.

    Time frame: Up to 2 days post-surgery.

07

Study locations

1 site
  • Yale University
    New Haven, Connecticut 06510, United States
08

References and documents

Publications

  • Ellahi A, Stewart F, Kidd EA, Griffiths R, Fernandez R, Omar MI. Strategies for the removal of short-term indwelling urethral catheters in adults. Cochrane Database Syst Rev. 2021 Jun 29;6(6):CD004011. doi: 10.1002/14651858.CD004011.pub4. PubMed 34184246 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 13, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03539107
Lead sponsor
Yale University
Responsible party
Sponsor
First posted
May 29, 2018
Start date
Sep 1, 2019
Primary completion
Dec 20, 2019
Completion
Dec 20, 2019
Last update
Jan 13, 2020

Study contacts

Harmanli Oz, MD
principal investigator · Yale University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion